System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Vincent Procaccio is an expert in Genetics at Centre Hospitalier Universitaire d'Angers (France). Vincent Procaccio has authored 264 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 900 (community average: 125). How the SLR is computed.

LeadR Profile

Vincent Procaccio Centre Hospitalier Universitaire d'Angers France
900 ScienceLeadR Reputation 900

Unlock

Register Login
Network Map

Genetics

Subspecialties: Neurology - Biochemistry - Nutrition

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1997 - 2026
Source: PubMed

University of Angers

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 264

Citations

Citations: 15 307 1st author: 10 Last author: 32 Unique author: 0

Main journals

Mitochondrion 10
Brain 8
Eur J Hum Genet 8
Hum Mutat 8
Am J Hum Genet 6

Best Journals

Science 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Optimized RNA-seq workflow for routine diagnosis of mitochondrial diseases using aberrant expression analysis and phenotype-driven prioritization.
PMID 42864382 — genes, mitochondrial diseases, workflow, phenotype, genome, rna-seq, diagnosis, complement system proteins, genetics, medical		Eur J Hum Genet20260
Ebselen restores mitochondrial function through metabolic rewiring in Barth syndrome and related mitochondrial diseases.
PMID 42834162 — mitochondrial diseases, cardiolipins, barth syndrome, therapeutics, lysosomes		EMBO Mol Med20260
Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study.
PMID 42280354 — pilot projects, cells, pilots, safety, neoplasms, diet records, carcinoma, renal cell, diet, immunotherapy, food, diet, ketogenic, weight loss, therapeutics		Nutrients20260
COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.
PMID 42218136 — up-regulation, cytochromes c, cytochromes, cytochromes c', brain diseases, electron transport complex iv		Nat Commun20260
Analysis of mitochondrial DNA heteroplasmy in sporadic ALS suggests technical limitations rather than disease association.
PMID 42035928 — high-throughput nucleotide sequencing, dna, mitochondrial, heteroplasmy, dna		Neurobiol Dis20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 1
Phase 2 1

By status:

Recruiting 1
Unknown 1

By type:

Interventional 1
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
MITOMICS a Multi OMICS Approach for the Diagnosis of Mitochondrial Diseases
NCT04920812 — muscular diseases, mitochondrial diseases, mitochondrial myopathies, muscles, multiple chronic conditions, rna-seq, diagnosis, fibroblasts, rna		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS